These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 8040406
1. Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris. Pariser DM, Pariser RJ, Ruoff G, Ray TL. J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):232-4. PubMed ID: 8040406 [Abstract] [Full Text] [Related]
2. Itraconazole in the treatment of tinea corporis and tinea cruris: comparison of two treatment schedules. Boonk W, de Geer D, de Kreek E, Remme J, van Huystee B. Mycoses; 1998 Dec; 41(11-12):509-14. PubMed ID: 9919895 [Abstract] [Full Text] [Related]
3. Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris. Parent D, Decroix J, Heenen M. Dermatology; 1994 Dec; 189(4):378-81. PubMed ID: 7873824 [Abstract] [Full Text] [Related]
4. A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor. Hickman JG. J Am Acad Dermatol; 1996 May; 34(5 Pt 1):785-7. PubMed ID: 8632075 [Abstract] [Full Text] [Related]
5. Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus. Tausch I, Decroix J, Gwiezdzinski Z, Urbanowski S, Baran E, Ziarkiewicz M, Levy G, Del Palacio A. Int J Dermatol; 1998 Feb; 37(2):140-2. PubMed ID: 9542675 [Abstract] [Full Text] [Related]
6. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Lachapelle JM, De Doncker P, Tennstedt D, Cauwenbergh G, Janssen PA. Dermatology; 1992 Feb; 184(1):45-50. PubMed ID: 1313717 [Abstract] [Full Text] [Related]
7. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris. Bourlond A, Lachapelle JM, Aussems J, Boyden B, Campaert H, Conincx S, Decroix J, Geeraerts C, Ghekiere L, Morias J. Int J Dermatol; 1989 Feb; 28(6):410-2. PubMed ID: 2548967 [Abstract] [Full Text] [Related]
8. Abbreviated oral itraconazole therapy for tinea corporis and tinea cruris. Sanmano B, Hiruma M, Mizoguchi M, Ogawa H. Mycoses; 2003 Sep; 46(8):316-21. PubMed ID: 12950901 [Abstract] [Full Text] [Related]
9. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study. Panagiotidou D, Kousidou T, Chaidemenos G, Karakatsanis G, Kalogeropoulou A, Teknetzis A, Chatzopoulou E, Michailidis D. J Int Med Res; 1992 Sep; 20(5):392-400. PubMed ID: 1333423 [Abstract] [Full Text] [Related]
10. The use of itraconazole to treat cutaneous fungal infections in children. Gupta AK, Nolting S, de Prost Y, Delescluse J, Degreef H, Theissen U, Wallace R, Marynissen G, De Doncker P. Dermatology; 1999 Sep; 199(3):248-52. PubMed ID: 10592406 [Abstract] [Full Text] [Related]
17. Oral therapy of common superficial fungal infections of the skin. Lesher JL. J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S31-4. PubMed ID: 10367914 [Abstract] [Full Text] [Related]
18. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Lebwohl M, Elewski B, Eisen D, Savin RC. Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304 [Abstract] [Full Text] [Related]
19. [Comparative evaluation of fluconazole 50 mg and 100 mg versus itraconazole 100 mg in the treatment of dermatomycoses]. Lospalluti M, Barile F, Pantaleo AK, Conese M, Guerra AP, Lo Re M, D'Amico G, Barbieri G. Clin Ter; 1994 Feb; 144(2):129-38. PubMed ID: 8181207 [Abstract] [Full Text] [Related]